Reddit Posts
$ENSC just broke down trend. News Oct. 19th, 2.7 mil float, price target $9-$18
$ENSC down 50% from its pop yesterday! Needs Volume to run again!
High Risk ENSC Stock: Buyers Crowdout Sellers. Final Stage Of The Phase ...
ENSC starting to take off - 600% CTB 100K available to short, float 4.61
ENSC - Ensysce Biosciences Announces Data from PF614-MPAR-101-Part A Successfully Demonstrating Opioid Overdose Protection
ENSC opioid drug for addiction overdose pain. recent rs. last week pos results in trial it moved from to about 1.20 under 2 Mill shares float. fintel has it shorted 17% and off exchange of 50%. small float high si already did rs positive news from trial. public offering at 1.40. 2$ if gets attention
$ENSC 707% Short Fee & only 25k shares left Ultra low float -DD
$ENSC, $DAKT, $BRQS, $IBIO- Down big ....on big volume
$ENSC insane ortex 👀 anyone in this play already?
💰💰💰Good morning! #premarket #watchlist 11/21 $WETG -Announces US$120 Million Agreement with Vmade Tech PTE. LTD, $COSM -to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines, $ENSC -earnings
How to get off from stock split stock?
ENSC some DD and personal opinion which will be in comments
TBLT just reported 76% increase in sales, .05 EPS and $28.5 in working capital - MASSIVE (millions) FTDS, 6% short
ENSC. Tiny float after R/S and just jumped from 900 watchers to 7000+ on ST. Has great tech to combat the opioid crisis! NFA.
Cheap Nasdaq Stocks Moving Up Today---
Been eyeing $ENSC for months, this gonna be the next runner in the coming week. 🚀 🌙 🚀 🌝 🚀 🌙 🚀 🌝 🚀 🚀 🚀
$ENSC undervalued and rock bottom opioid play - sunday bad DD
ENSC vs TTOO… May the Best stock win!
ENSC - Projected to reach $10 in upcoming months. The stock is at the very bottom and funded from NIDA so they seem rock solid, They have a corporate call shortly and it’s going up and up, jump in so you don’t miss on this. Got myself a good coverage as well!
ENSC REVERSE STOCK SPLIT COMING? just got this in mail
ENSC Bioequivalence results due by next week and another trial with results expected in September..it has already put out invites to begin partnership
In your opinion, what is the best pennystock to buy that is currently priced between $0.25c - $0.75?
I called out $REVB, now it’s time for $ENSC to run up 100%. Mark my words.
ENSC waiting for results this quarter.. it could replace much of oxycontin prescriptions.. what you think about 🤔
VOLUME 🚨 100M volume can literally squeeze $ENSC a minimum of 200%‼️‼️‼️ Float 14M with 29M shares outstanding 🤯 Currently $1 with price targets up to $23 🚀🚀🚀 Reported 12.3M cash ending 2021 compared to 0.2M ending 2020. Trial results coming out Q2 with enough cash until 2023 so no offerings 😎
LETS SQUEEZEEEEE $ENSC 😎 Super low float!!!
High CI plays for Next Week (4/18-4/22)
ENSC loaded before results in Q2.. it could be the next SBFM
ENSC volume increasing probably results incoming.. 💣🚀
ENSC could be the next SBFM.. results in Q2 with a very low float
ENSC. Solid pipelines, large recent inflow
someone that has ENSC ortex data ...
Anyone looking at $ENSC. Going to boost today on good news. Could easily see above $2
ENSC!!! STATE OF THE UNION OPIOIDS Crisis
ENSC needs a little push, ready to fly!
ENSC. Ok this is fkn insane. Is this for real?
ENSC is squeezing!! Get in now and buckle up 🚀🚀🚀
ENSC is squeezing! Get in not and buckle up 🚀🚀🚀🚀🚀
sighh ENSC covering, it kills the shortsqueeze
Top 25 Short Squeeze Stocks - January 3, 2022: SYTA, AVCT, ENSC, SDC, IINN
Fintel's #ShortSqueeze Screener and Leaderboard for all you thirsty Short Squeezers. $ISIG $PTPI $AVCT $SEAC $IINN $SPRB $STRN $ENSC
ENSC CTB MAX 394.84% Same insane cost to borrow like AVCT..
$ENSC has very high CTB and is going to fly. Short Squeeze Score 96%
$ENSC might only be steps away from squeezing up
Daily Squeeze Data: December 29, 2021 - $ISIG, $PTPI, $ENSC, $LMND
Daily Squeeze Data: December 29, 2021 - $ISIG, $PTPI, $ENSC, $LMND
One big reason to have diaomond hands for ENSC! ANSON funds Under investigation by the DOJ
AVCT - From 147K shares shorted to 4.71M in 4 weeks. Per Nasdaq
ENSC - Is primed to run more than you all realize Lets take a look at the DD
ENSC ranked for "Strong Buy" Candidate on Stockinvest (a rare feat)
$ENSC - Literally flying under the Radar, and with Good Data; Final Updated DD.
ENSC ready for $8 after hours! Load up now!
Here’s your chance for entry in ENSC!
$ENSC - Literally flying under the Radar, and with Good Data
ENSC small float bio seeking to address pain management
ENSC Stock Relentlessly Defying Sellers. How High Can It Go?
How did we miss ENSC lol?! This thing is shorted to oblivion…the borrow fee is at 200% look like it just started to squeeze , I slapped 20 bucks on it for the hell of it 😂
ENSC - It looks like the Shorts have reached their limit.
Just solidly asking : who think about ENSC to be good forward, like last week ? I'm in yet , and think it will get back near it's earlier price soon (~10$ ) ...
ENSC with enough support, could be easily get a 7-8$ PT ...
ENSC buyers at the gate, who will assist them to get into the castle ? I'm in ... Shortsqueeze for this stock ? What do you think guys ?
ENSC can be huge next week and this is why. Serious shit. Trapped more shorts today, given a PT of $23 and many gaps to fill this can fly. 👀💰💰 Who's in?
ENSC can be huge next week and this is why 👀💰 Given a PT of $23 and gaps to fill it will be huge!
ENSC can be huge next week and this is why 👀🔥
ENSC better go up for your sakes for I will release an unspeakable ruthless rampage over this chat if it doesnt
Does anyone have ENSC short interest and other data? Lot of buying pressure just before close, this can run again with this $23 price target! (Currently $4.4)
Looks like ENSC is setting up another nice trend. 🚀
Who think ENSC became a hero runner-up forward from this, starting on monday ? AH today will be interesting or just usual ? Thoughts ?
Mentions
ENSC potential 50 bagger in two years. TCON potential 5 bagger in 3 weeks Place your bets
YES! When you can help end the Opiate Epidemic w/ $ENSC... Rock bottom price, second leg of a double bottom on a 5 year chart. Nearly the same price & FDA approval will be by March 24th...
ASLN, NKGN, GRI, TPET, TCBP, RVSN, VLD, YOSH, ENSC, and just maybe FSR. look into it my G
currently looking into ENSC & NKGN, have not made a decision yet. Primary drive is #TCBPTakeOff 🧬🌙 just bought even more shares about an hour ago 🦠🔬
Get in ENSC . 50X incoming. No worries about squeezing
You want a 50 bagger??? ENSC and thank me after a year
Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se
Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se
Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se
Hot Stock To Check Out- FDA Breakthrough Therapy Heading to Phase III I did some research - please take a look as this could explode over the next year!! https://ensysce.com/ Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se
Hot Stock with FDA Breakthrough Designation!!!! Ensysce Bioscience- ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come… $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se https://ensysce.com
The opioids crisis continues to be a plague on society - they have Breakthrough Therapy Designation- which very few drug therapies get. Hopefully with that because they review results as they come in by the end of the year early next year they could go to market. Also, below is another collaboration. They have with a Swedish Pharma company that could be huge as well. We just need to continue to push the word on Reddit to get more people aware of what ENSC is doing and potential. $ENSC Another collaboration with a company developing another pain product entirely different from opioids to treat oral mucositis in patients with cancer, people who are undergoing radiation or chemotherapy, and alterations in the mouth. This product is being evaluated in Europe and ENSC has become the American arm of the company developing it. They working with them to try and get it on the market here to help people with cancer alleviate their pain as well. This is their partners website - https://oncozenge.se
So ENSC could be a long term buy... I dont know FDA timing for approval, but reading your post and doing some research about Phase 3 it could be in 1 or 2 year from now, right? I see the price is pretty low now, do you think it could be lower?
ENSC is the stock ticker Think about it folks so many Bio Pharma claim to have a cure for cancer. ENSC has a niche to help/solve the Opioid Crisis that gets worse every day. Basically they have something that no one else has- niche market and FDA approval happens the price will skyrocket! $ENSC The impact of the Breakthrough Therapy Designation from the viewpoint of large pharmaceutical companies: Big companies know what the FDA thinks of this treatment: "A breakthrough therapy designation is for a drug that treats a serious or life-threatening condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement on a clinically significant endpoint(s) over available therapies." 2. Average approval time reduced by 2.5-3.5 years. 3. Less money is required- possible to reduce 50% of overall development cost. Patnership/buyout is almost guaranteed and that’s when the big payoff will come…
LAES, ENSC ICU. ICU is going to run. 100 percent plus. 2 catalysts this week coming
I also had the please of watching ENSC going down 25% since yesterday. Also a hype by. But this one is holding a little more stable. Wish me luck lol
I missed that $ENSC pump this morning. Feel wrecked.
No one is looking on $ENSC but I think this gonna skyrocket for a few folds imo
Im new here— i got kicked out of short squeeze because the mod said i belong here— any way— here are solid ideas. Not all will be possible, but will be profitable if you can enter at these levels 1. LAES 1.58 2. PHUN. .22 3. ICU .65 4. ENSC 1.40 5. RUM 5.35 All entries are possible—- maybe all next week. A month from now, this post is worthless. But any should yield 20-50 percent next week—swing trade style
Whats going on with $ENSC and $BCLI?
It's definitely ENSC - I don't really understand the product and it's a little high for me but I think it does have potential, at least the opioid epidemic could use some help. I'm bullish on psychedelics, even for addiction!
This one could hit $2 in a week and still be cheap based on existing trials and the market available. ENSC could be a huge solution for the opioid crisis in the world. ENSC has a better product than oxycodone, with very little chance of OD.
$ENSC - VERY Undervalued. Currently $1.6, price target $9-$18 by HC Wainwright & Co. Analysis. News Oct. 19th, 2.7 mil float. Also broke the downtrend and has just started the curl upwards
I’m going in on ENSC. Volume is high on no real news, hoping Monday it pops off.
My eyes are on ENSC, BWV, and HLGN but I think it's early for them, not buying just yet.
Thanks for answering my thread about CVNA , I appreciate it. I had mentioned that I would throw everything else into some bio stocks (ENSC, CVAV, NWBO) but I had luck in the past with VBIV (got some options for Jan 24). It’s not a squeeze per say play but I believe that this stock is insanely undervalued. Would love to hear your thoughts about VBIV. It’s still somewhat under the radar but slowly keeps getting more attention. Thanks
I bought all the small pharma stocks in 2022. I’m never getting my money back from ENSC, DNA, GSM or OCGN so I’ll be ignoring all the next miracle cure makers for the rest of my life savings
ENSC been waiting on this one for a while! If the VA gets involved it will be something special! Helps people combating addiction to pain killers. It’s been death spiral financing was over $11 a few months ago and now under a buck is a steal.
>ENSC All of that just because of a phase 1 initiation?
ENSC today. They have a drug that blocks overdoses and regulates oxycodone release. Can’t crush, chew, snort, oxy . Conference sometime today I believe
Well, today was a fucking nightmare. On top of the damn HKD disaster sold a all my ENSC holdings after seeing another SRC filling, assuming it was another dilution. My average was .63 and I really believe in their opiate OD blocker...oh and the cost to borrow was around 550. Not a good day but there's always tomorrow. Can't be emotional like I was today, it really screw's things up. I'm still holding the P&D but hope I will at least come close to even. From now on I will only concentrate in small cap bio stocks, preferably Covid related. For others bin the same sinking ship, good luck today!
No problem. Not financial advice but watchlist recommendations: GOVX, ENSC, NRSN and AUVI. I'm watching closely for added volume and/or news.
ENSC looks…interesting. Already had a RS in October. Not impressed with the volume, but the float,CTB rate and the coming results in March of the drug trial, announced as complete yesterday, has my attention.
I'm so bad at predicting. It seems I am usually spot on the day of the squeeze like today with BOXD (though I deleted that post for various reasons) or I'm three weeks early, occasionally up to six. With the high CTB you would think it would be soon, but ENSC has been in the same situation and is taking its own sweet time.
ENSC information from you spoke about it?
ENSC…announced today phase 2 completed, %546 CTB W/100k available.
ENSC has my attention. GL
Thanks, today was a strange day. ENSC kept going down for quite a while and today went up 20 percent.
That just happened. I researched bio stocks that have an interesting pipeline and they came up. ENSC was a bit over $2 right before I bought it, then they did an offering and it dumped. Today it went up 20 percent for once.
Good dd on those stocks. Nice pick on ENSC I see it is doing good.
Good dd on those stocks. Nice pick on ENSC I see it is doing good .
ENSC happening now. Not financial advice.
I'm in 3 bio stocks right now and feel pretty good about it. It's not a short squeeze (maybe one since the short selling fee is 647.56%) They are all penny stocks 1: ENSC —high borrow fee but had/has quite a bit of dilution I bought in at .63 because I like what the company is working on...Ensysce’s proprietary MPAR™ (Multi-Pill Abuse Resistance) technology can turn off the activation when too much TAAP medication is taken. This does not affect the effectiveness of MPAR™ products when taken as prescribed. 2: Northwest Biotherapeutics Inc— OTCMKTS: NWBO Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers. They are also in the midst of a lawsuit against stock price manipulation by short sellers. Got in at .83 3: VBIV https://www.vbivaccines.com Has a Hep C vaccine FDA approved Also received 33 million funding from the Coalition for Epidemic Preparedness Innovations to develop a multivalent vaccine against Covid 10 and other coronaviruses. This stock is at its 52 week low at .38 Huge upsides on all three with minimal downside at least in my opinion.
▫️VBIV: -Receives U.S. FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma. -FDA just approved their Hep B vaccine: PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] is the only approved 3-antigen hepatitis B vaccine for adults in the U.S. -The Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potential variant-proof coronavirus vaccines in a deal with VBI Vaccines Inc. (Nasdaq: VBIV) to advance the development of multivalent coronavirus shots that could be deployed against COVID-19 as well as a future ‘Coronavirus X’. ▫️ENSC: -Stock tumbles 49% during pre-market. That was a few days ago but it's still down due to the offering. Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. -prices an underwritten public offering of 2.9M shares and warrants to purchase up to an aggregate of 5.8M shares at a combined price of $1.40 per share of common stock and accompanying warrants. Each warrant is exercisable immediately at an exercise price of $1.40 per share and will expire five years following the date of issuance. Company expects to receive aggregate gross proceeds of ~$4.1M. Offering is expected to close on or about December 9, 2022. Underwriter's 45-day option to purchase up to an additional 342,000 shares and/or warrants to purchase up to an additional 870,000 shares. 20% of the gross proceeds will be used to repay a portion of the company's outstanding convertible notes. Remaining proceeds for the further clinical development of its product candidates.
Uhm, so I've been doing a little DD on it and to be fair, I don't really know my ass from a hole in the ground but thankfully I know how to read and I can also type so I can ask Google questions when I am confused.... So I tell you all that to tell you, I don't think an offering is going to be good in the short term. If this is a play, I feel like it's a play that is a ways off, like when their drug actually makes it to market. And again, I don't know shit....but their earnings appear to look like shit, the company currently isn't profitable. But again, idk 🤷 BUT....for a grand finale....I want to mention QTNT. In ENSC third quarter finances, they mentioned a partnership with QTNT. Which is currently trading at .60 some cents and is a bottomed out chart. Had a 52 week high of 112. If ENSC DOES pop, so will this little guy. Something to look out for
When will the dilution be reflected in the ENSC share price?
Addiction overdose pain?? Tf is that bro?!😂😂 You ain't never been addicted to heroin and it really shows... Idk who produces methadone, or the newest one Suboxone. But whatever drug ENSC is making is supposed to rival those two
I'm down 33% I was down 45% but in last month or so I'm up 10% mainly because of USEA got in at 1.65 and timing and playing COMS COSM hlbz. Now I'm looking at ENSC low float high si positive trials for opioid addiction overdose and pain. Public offering at 1.40 for 2.9 Mill shares and warrants 5.8mill at 1.40 expire 5 years from aggregate date
I was referring to the tech that ENSC is developing; not the drugs that led to people within your inner circle wanting to kill themselves
$ENSC seems to be getting buzz on Twitter for a big gap up play. This dude and some other big accounts on it. Definitely not a pump and dump https://twitter.com/_TraderZero_/status/1600140306971648002?t=kmrOqhuLjnTOPyADw8PfEQ&s=19
ENSC, NWBO, and most importantly VBIV.
Offering stocks: IBIO, ENSC, BRSH, VS
If you want to play hot potato with a grenade, go for it. ZEV would be a smarter play. So would ENSC. I could name a dozen... Doesn't the new short report come out tonight? Maybe the decision should be made on Sunday like you guys used to do.
I’m getting more MMAT. How about ENSC?
Serious question or not? I got in ENSC
Exactly. Like NRBO and ADTX did. What do y’all think of ENSC?
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: ENSC CNXA IMPP HSDT QH VRAX KTRA. We don't allow discussion of low market cap (less than 500mm) tickers to prevent pump & dump spam and scammers.
Not yet but there are many other. CSCW, ENSC, ATXI, PALI, KPRX, KTRA, MOHO, SONN, NBRV, SPCB and many other.
ENSC has a upcoming stock split, it's under 0.40 right now, take a small position and hold it will pay off, don't worry bro.
We have so many sinister people in this world., it's a complete shame. Hopefully this makes you feel better. I'll set a reminder when I profit off of ENSC, but I'll forget your username because I've already found god in the world. Have you?
Thanks buddy, that's very kind of you :) To give a small update, I've taken a small position in ENSC. Their pro-drug system is a proven concept in my opinion and the anti-overdose part of their research is potentially ground breaking as far as I'm concerned. The research is in early stages (stage I and II trials so far) but are granted fast track designation and supported by a grant of the FDA which sounds promising. I most certainly don't think the stock is a sure bet but i think the potential upside is enormous.
Your clown statement said nothing. Nothing. Talk about the trial results and the technology and how it works. Puzzled_Raccoon8169 is a fraud talking about ENSC. There are “abuse deterrent formula” (ADF) opioids that have some reduction to abuse but they don’t eliminate it. Ensysce’s lead product PF614 is through Phase II AND Bioequivalence studies and it ELIMINATES abuse. Why? Ask the fraud Puzzled_Raccoon8169 to explain why. Oh, he can’t because he is a bot just slamming on the stock without knowledge. Allow me. The reason abuse is ELIMINATED is because the TAAP prodrug only activates the opiate when the digestive enzyme trypsin is present. The active form of trypsin can only be found in the intestinal tract. It’s created in the inactive form In the pancreas but active in the intestinal tract. Without trypsin the opioid doesn’t activate so it must be ingested. You can’t snort it or inject it. It doesn’t activate with saliva or blood. What’s even better? It has an overdose-resistant prodrug MPAR. Again. Ask this clown Puzzled_Raccoon8169 to explain MPAR. What? You mean he doesn’t know jackshit about the BioTech here? Ok. I will fill you in for that shit talking clown. MPAR senses the level of opioid activated and will release a trypsin inhibitor Nafamostat. If the opioid begins to exceed the dosage limit the activation shuts down preventing overdose. The 2023 Opioid global market is $30 Billion. That market will not only be increased by the presence of the world’s first safe opioid but will be dominated by the owner of it. Ensysce claims their technology can be applied to many drugs including amphetamines (in Phase I). There are many drugs that incur common misuse and Ensysce’s technology will be applicable to many of them. Can you imagine the monetary value of all the markets it could impact? Yes. This Puzzled_Raccoon8169 is a fraud. He doesn’t know anything about this company and threw out some generic phrases. Ignore him. The OP is correct with a few things including the King buyout by Pfizer for Embeda in 2010 for $3.6 Billion. It’s 12 years later and PF614 is a significantly more superior product and the Ensysce technology is applicable to many drugs. The buyout potential here is huge. One more thing. Ensysce sits before the FDA for fast track approval in early 2023. If it gets that far before a buyout a bidding war from Big Pharma is happening because the lead product is 12-18 months from production and that point
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: ENSC. Message /u/zjz if they're above 500 million-ish market cap and not related to crypto/pennies/OTC.
Addiction doctor here; I don't know much about the company ENSC but after reading their product page i'm cautiously enthusiastic. Pro-drugs are nothing new and a hypothetical prodrug of oxycodon/hydrocodon/methadone will be many times as expensive as the generic variant. However, Americans are seemingly willing to spend way more on drugs than Europeans and considering how enormous the opiate crisis over there is there may be money to be made. Besides this, the stock is dirt cheap (has a market cap of 20 million!?) and prodrugs such as lisdexamfetamine are a proven concept. Ill have to read in to this stock a bit more (sadly fundamental analysis is not my forte...) but I'm considering taking a position on this one.
Can I ask about your methodology and reasoning? These all sound good to me, but so too do the pages upon pages of other promising biotech up-and-comers. I don't have a background in biotech, so I pretty much have to randomly guess at variables like how innovative and useful the product is and the likelihood of clearing regulatory hurdles. Now that I've convinced you that I don't know what I'm doing, I have positions in Dare Biosciences (DARE) and Evofem Bioscience (EVFM) -- both of which are in the reproductive health game -- as well as Ensysce Bioscience (ENSC) which is developing an abuse-resistant opioid.
I have a few million shares of HCMC. Bought in at .0002 and my plan is to let it sit for ever. Hoping they keep opening new stores and partnering with other outfits. The owner is a POS which at some point you would think he would want to cash in unless he already cashed in his chips. The 340 billion outstanding shares really hold this thing down. I have been buying millions of different sub penny stocks in hopes of a hit long term. One that is not sub penny I am sitting on that I have big hopes for is ENSC.
ENSC ready to pop .. Results will come out this week
ENSC ready to take off.. Results will come out this week
ENSC ready to go.. Results come out this week
ENSC - About to solve the Opioid problem. Currently $.60
Shittt ENSC about to double up I’d say around 2 or tomorrow 👏🤧💤
CTXR, ACRX, ENSC, RMO, SFT, CHEK. P.s. some of there were in double digits when I made first purchase.
Solid callout on ENSC. What’s the move for today champ?
Def saw REVB popping on Wednesday and made solid gains yesterday morning. What are you feeling today? ENSC had pretty good movement yesterday but we’ll see how it does in PM
Missed ENSC earlier but I think it’s got some gas left in the tank. I like the chart along with the volume and P/E ratio. Is this on anyone else’s mind
Why is ENSC up? What’s the news?
$ENSC currently making moves. I’ve been holding since April, figured there would eventually be news about their development of their abuse-resistant opiates. Other than obtaining another years worth of funding, haven’t seen any reason for it to be going up like it is. I’m suspecting some amounts of insider trading. Thinking there must be something coming soon, tomorrow or another day, that will have it shoot off soon. Might be a good time to buy in.
buy ENSC @ .50 cents .....then sell it at @ .51 ....boom just made you some money
CEAD and ENSC time for them to fly ?
Buy NYMX and ENSC its like 50 cents so we can all make a little money if we work together
ENSC & NYMX Are seeming like good stocks to try and start trading trading with... I'm not a market guru or anything so I'm asking for input on my observation
Buying more BBIG & ENSC
im still waiting for ENSC and CEAD to do there thing ! I still have faith